Cleared Traditional

Bunkerhill Contrast AVC (K260167) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K260167 · BunkerHill Health · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2026
Decision
45d
Days
Class 2
Risk

K260167 is an FDA 510(k) clearance for the Bunkerhill Contrast AVC. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by BunkerHill Health (San Francisco, US). The FDA issued a Cleared decision on March 6, 2026 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all BunkerHill Health devices

Submission Details

510(k) Number K260167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 2026
Decision Date March 06, 2026
Days to Decision 45 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 107d · This submission: 45d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
John Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 421
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K260167.
Extremity CT Imaging System
K252249 · Mars Bioimaging , Ltd. · Mar 2026
Aquilion ServeSP (TSX-307B) V2.0
K260078 · Canon Medical Systems Corporation · Mar 2026
Bunkerhill Contrast CAC
K260166 · BunkerHill Health · Mar 2026
AV Cardiac CT
K260169 · Philips Medical Systems Nederland B.V. · Mar 2026
uCT 780 with uWS-CT-Dual Energy Analysis
K253173 · Shanghai United Imaging Healthcare Co., Ltd. · Jan 2026
CT VScore+
K252217 · Canon Medical Informatics, Inc. · Nov 2025